Hangzhou AGS MedTech Co., Ltd.

SHSE:688581 Stock Report

Market Cap: CN¥4.7b

HangzhouS MedTech Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Cheng Zhang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership40.0%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

There May Be Underlying Issues With The Quality Of HangzhouS MedTech's (SHSE:688581) Earnings

Apr 29
There May Be Underlying Issues With The Quality Of HangzhouS MedTech's (SHSE:688581) Earnings

Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Looks Inexpensive But Perhaps Not Attractive Enough

Apr 24
Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Looks Inexpensive But Perhaps Not Attractive Enough

CEO

Cheng Zhang

no data

Tenure

CN¥2,488,600

Compensation

Mr. Cheng Zhang is Chairman & General Manager of Hangzhou AGS MedTech Co., Ltd.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.